نتایج جستجو برای: bcl2

تعداد نتایج: 4227  

Journal: :Cancer discovery 2017
Joel D Leverson Deepak Sampath Andrew J Souers Saul H Rosenberg Wayne J Fairbrother Martine Amiot Marina Konopleva Anthony Letai

Since the discovery of apoptosis as a form of programmed cell death, targeting the apoptosis pathway to induce cancer cell death has been a high-priority goal for cancer therapy. After decades of effort, drug-discovery scientists have succeeded in generating small-molecule inhibitors of antiapoptotic BCL2 family proteins. Innovative medicinal chemistry and structure-based drug design, coupled w...

Journal: :Cancer research 1990
J C Reed C Stein C Subasinghe S Haldar C M Croce S Yum J Cohen

Antisense oligodeoxynucleotides specific for sequences in mRNAs from the B-cell lymphoma/leukemia-2 (BCL2) gene were used to inhibit the growth in culture of a human leukemia cell line, 697. Normal phosphodiester (PO) and nuclease-resistant phosphorothioate (PS) oligodeoxynucleotides were compared with regard to specificity, potency, and kinetics. Both PO and PS antisense BCL2 oligodeoxynucleot...

Journal: :Croatian medical journal 2008
Petra Korać Mara Dominis

AIM To explore the association between FOXP1, BCL2, and BCL6 gene expression in diffuse large B-cell lymphoma tumor cells and their association with the presence of FOXP3 lymphocytes. METHODS Samples of lymph nodes from 53 patients with newly diagnosed diffuse large B-cell lymphoma were taken at the time of the diagnosis and immunostained for CD10, MUM1, BCL6, BCL2, FOXP1, and FOXP3. Fluoresc...

Journal: :Molecular cancer therapeutics 2016
Ryan S Soderquist Alan Eastman

Antiapoptotic BCL2 proteins play a major role in tumor cell survival. Hence, BCL2 inhibitors have been developed as direct inducers of apoptosis. ABT-199 (venetoclax) received breakthrough therapy designation from the FDA due to its apparent efficacy in CLL and AML. However, resistance to ABT-199 is mediated by other BCL2 proteins including BCLXL and MCL1. Considerable effort has been expended ...

2014
A Barreca C Martinengo L Annaratone L Righi A Chiappella M Ladetto A Demurtas L Chiusa A Stacchini N Crosetto A van Oudenaarden R Chiarle

Most follicular lymphomas (FLs) are genetically defined by the t(14;18)(q32;q21) translocation that juxtaposes the BCL2 gene to the immunoglobulin heavy chain (IgH) 3' regulatory regions (IgH-3'RRs). Despite this recurrent translocation, FL cases are heterogeneous in terms of intratumoral clonal diversity for acquired mutations and variations in the tumor microenvironment. Here we describe an a...

2015
Ting-Xun Lu Lei Fan Li Wang Jia-Zhu Wu Kou-Rong Miao Jin-Hua Liang Qi-Xing Gong Zhen Wang Ken H. Young Wei Xu Zhi-Hong Zhang Jian-Yong Li

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL). Patients with DLBCL harboring MYC aberrations concurrent with BCL2 or/and BCL6 aberrations constitute a specific group with extremely poor outcome. In this study, we retrospectively investigated the incidence and prognosis of MYC, BCL2, and BCL6 aberrations with DLBCL patients in Chinese population. We applied ...

2017
Charlotte Viant Sophie Guia Robert J. Hennessy Jai Rautela Kim Pham Claire Bernat Wilford Goh Yuhao Jiao Rebecca Delconte Michael Roger Vanina Simon Fernando Souza-Fonseca-Guimaraes Stephanie Grabow Gabrielle T. Belz Benjamin T. Kile Andreas Strasser Daniel Gray Phillip D. Hodgkin Bruce Beutler Eric Vivier Sophie Ugolini Nicholas D. Huntington

Natural killer (NK) cells are innate lymphoid cells with antitumor functions. Using an N-ethyl-N-nitrosourea (ENU)-induced mutagenesis screen in mice, we identified a strain with an NK cell deficiency caused by a hypomorphic mutation in the Bcl2 (B cell lymphoma 2) gene. Analysis of these mice and the conditional deletion of Bcl2 in NK cells revealed a nonredundant intrinsic requirement for BCL...

Journal: :Blood 2012
Abner Louissaint Adam M Ackerman Dora Dias-Santagata Judith A Ferry Ephraim P Hochberg Mary S Huang A John Iafrate Daniel O Lara Geraldine S Pinkus Itziar Salaverria Zakir Siddiquee Reiner Siebert Howard J Weinstein Lawrence R Zukerberg Nancy Lee Harris Robert P Hasserjian

Pediatric follicular lymphoma (PFL) is a variant of follicular lymphoma (FL) presenting as localized lymphadenopathy in children. Unlike conventional adult FL, PFL typically does not recur or progress. Clear diagnostic criteria for PFL are lacking, and it is uncertain whether this indolent lymphoma is defined by age or may occur in adults. We analyzed 27 FL in patients < 40 years of age and fou...

Journal: :Cancer research 2004
Gerhard Regl Maria Kasper Harald Schnidar Thomas Eichberger Graham W Neill Michael P Philpott Harald Esterbauer Cornelia Hauser-Kronberger Anna-Maria Frischauf Fritz Aberger

Aberrant activation of the Hedgehog (HH)/GLI signaling pathway has been implicated in the development of basal cell carcinoma (BCC). The zinc finger transcription factors GLI1 and GLI2 are considered mediators of the HH signal in epidermal cells, although their tumorigenic nature and their relative contribution to tumorigenesis are only poorly understood. To shed light on the respective role of...

Journal: :Cancer research 1998
S Haldar A Basu C M Croce

Taxoids and other microtubule-damaging drugs are known to induce Bcl2 phosphorylation at the G2-M phase of the cell cycle, with concomitant apoptosis in malignant cells derived from a variety of human malignancies, including leukemia, lymphoma, and breast and prostate cancer. We have investigated the ability of another antineoplastic drug, dolastatin 10, in inducing Bcl2 phosphorylation and apo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید